The commitment should fall in at least one of five commitment areas to participate:. The map image was updated on August 9, Email ARX cdc. The following commitments were updated on September 6, Visit the site each month to see recently added commitments. The 98point6 Clinical Quality Assurance team tracks adherence to antibiotic guidelines and reports this data across the company and to partners. By year-end, the company plans to build and implement consistent ways of communicating the importance of proper antibiotic usage to providers and patients, as well as expand practice standards and clinic training in this area.
When patients request antibiotics, 98point6 clinicians use standardized antibiotic stewardship language. After visits, patients receive robust information about antibiotics within the application. These new antimicrobial and antibiofilm technologies will treat wound and medical device related infections, and will provide an alternative treatment to antibiotic classes in which bacterial resistance is high. By providing alternative treatments to existing antibiotics, it is anticipated that the global use of antibiotics could be decreased significantly.
Abt Associates Inc. Massachusetts, U. Abt Associates—a global company that conducts research, consulting, and technical services in health, environmental and social policy, technology, and international development—commits to pursuing opportunities within new and existing global projects to conduct antibiotic resistance mapping, landscaping, and trend analysis. In particular, Abt Associates aims to help better understand the status and threat of antibiotic resistance among private health facilities and pharmacies worldwide, among formal and informal providers, and to collect data on contextual factors that contribute to antibiotic resistance in particular geographic regions.
Abt Associates plans to share resistance data, news, and information from these projects via multiple external communication channels and existing project reporting relationships to CDC and USAID. Accelerate Diagnostics, Inc.
Antibiotic resistance plan to fight 'urgent' global threat - BBC News
Arizona, U. These diagnostic solutions, the first of which is currently in use in hospitals around the world for bloodstream infections, will help clinicians tailor therapy for 5 million patients within the next 5 years. AdvaMedDx is committed to improving patient care and public health through increased access to appropriately used diagnostic tests for early detection of resistant infections, informed prescribing of antibiotics, and surveillance in the fight against antimicrobial resistance AMR.
Adventist Development and Relief Agency Adventist Development and Relief Agency ADRA , a humanitarian organization providing long-term development programs and emergency response internationally, commits to working with its national offices, partners, stakeholders, and donors to raise awareness for equal access to safe water, adequate sanitation, and a hygienic environment in all healthcare facilities. Additionally, ADRA commits to providing healthcare services that respect the dignity of all users and staff in order to improve health outcomes.
As one of the largest health insurers in the U. We do that by partnering with state health departments to offer feedback to providers about their antibiotic prescribing performance, integrating stewardship metrics in our value-based contracts, and promoting vaccinations. ACHAP commits to contributing to policy dialogue and implementation; sharing expertise, experiences and success stories; strengthening health systems; instituting WASH mentorship and coaching programs; and promoting social accountability mechanisms to ensure community participation and ownership for WASH in healthcare settings.
ACHAP commits to undertaking research, analysis, advocacy, and communications; building culture and consciousness to ensure sustainability and resilience in health services; and promoting WASH as a tool towards attaining Universal Health Coverage. This will be executed by providing trainings, webinars, and newly developed educational tools for healthcare workers and patients on appropriate antibiotic use and antibiotic resistance. ALK Denmark Through educational programs and onsite support, ALK, a global pharmaceutical company, commits to educating healthcare providers in inpatient and outpatient facilities across the U.
Implementation of these services could reduce the unnecessary use of broad spectrum and sub-optimal antibiotics and contribute to improved patient safety.
- 101 Dog Tricks: Step by Step Activities to Engage, Challenge, and Bond with Your Dog.
- 5 minutes to explain- antibiotic resistance;
- Pleiadian Perspectives on Human Evolution.
- Antimicrobial Resistance.
- Antibiotic resistance plan to fight 'urgent' global threat.
- Antibiotic Policies: Fighting Resistance by Ian M. Gould (ebook).
ALK supports the National Penicillin Allergy Day campaign and strives to see increased participation from healthcare providers and practices in The American Academy of Emergency Medicine AAEM , a professional society with over 8, emergency physician members, commits to developing and promoting the first antibiotic stewardship pledge for emergency care providers. This pledge incorporates stewardship principles relevant to the emergency department setting.
In addition to featuring a general commitment to improve antibiotic prescribing, the pledge includes condition-specific statements aimed at optimizing care for infections frequently treated in the emergency department such as sepsis, respiratory tract infections, and urinary tract infections. AAEM will also regularly incorporate infectious disease educational topics into continuing education offerings such as its annual Scientific Assembly. The American Academy of Orthopaedic Surgeons AAOS will increase awareness among its 38, members in more than countries of evidence-based strategies to prevent and treat surgical site infections and periprosthetic joint infections.
AAOS will also increase awareness of when antibiotics should and should not be used for patients with hip and knee implants who are undergoing dental procedures. AAHA will also have educational tracks at numerous veterinary conferences in to educate and inform veterinary colleagues about the new ICPB guidelines to promote the highest standard of care for animals.
The AAHA Standards of Accreditation include many standards related to infection prevention and control, sanitation, and stewardship. The American Association of Avian Pathologists AAAP commits to maintaining poultry health and welfare by implementing strategies to prevent, control, and treat common diseases by using an evidence-based approach in antimicrobial decisions, then using antimicrobials judiciously and with continual evaluation of the outcomes of therapy while protecting poultry health and ensuring safe, affordable food to the consumer.
Also as part of its mission is to promote scientific knowledge to enhance the health, well-being, and productivity of poultry to provide safe and abundant food for the world, AAAP is committed to collecting and tracking on-farm antimicrobial use data by AAAP veterinarians who are assisting with a project to quantify on-farm antimicrobial use within the U.
The American Association of Nurse Practitioners AANP , representing , nurse practitioners across the United States, commits to raising awareness of infection prevention and appropriate antibiotic use among nurse practitioners and patients. AANP will provide its members with information about antibiotic stewardship in its two peer-reviewed journals The Journal of the American Association of Nurse Practitioners and The Journal for Nurse Practitioners , newsletters, website, social media, and conferences throughout American Cancer Society Georgia, U.
The American Cancer Society commits to increasing patient awareness of the importance of infection prevention and control, as well as antibiotic resistance, through website and blog communications materials. With , members of internal medicine physicians, medical students, residents, and fellows, the American College of Physicians ACP will continue incorporating evidence about antibiotic stewardship into clinical policies relevant to antibiotic treatment and prophylaxis, and publish an opinion piece in a peer-reviewed journal to spread awareness of the urgency of the issue.
American Dental Association Illinois, U. The American Dental Association ADA commits to creating and disseminating guidance to help clinicians appropriately prescribe antibiotics for dental pain and swelling. The ADA also commits to publishing a survey of current antibiotic prescribing practices among dentists to demonstrate the need for such guidance.
American Hospital Association Illinois, U. The American Hospital Association AHA will work with its members to prevent infections and reduce the spread of germs, and improve the use of antibiotics wherever they are used. Specifically, AHA will support hospital members to improve antibiotic use, solicit commitments to implement targeted assessments for infection prevention TAP , support containment of emerging resistance with state and local health departments, and provide patient education on antimicrobial resistance.
AHA represents nearly 5, member hospitals, health systems, and other health care organizations; clinical partners—including more than , affiliated physicians, 2 million nurses and other caregivers; and 43, health care leaders belonging to their professional membership groups. APHA advocates for a One Health approach, focusing on human and animal health, and will continue to advocate for increased public health funding on antibiotic resistance. The American Society of Consultant Pharmacists ASCP is an international association representing more than 8, pharmacy professionals and students who serve the unique medication needs of older adults.
ASCP commits to promoting antibiotic stewardship across the spectrum of older adult care through practice resource development, industry partnerships, educational materials, and proactive market research and support. American Society for Microbiology Washington, D. With its 30, members in countries, the American Society for Microbiology ASM is committed to working with global stakeholders to develop and execute a roadmap for surveillance and monitoring of antibiotic use and antibiotic resistance. ASM currently works across countries and sectors to establish, bring to scale, and sustainably maintain such systems by focusing on strengthened laboratory capacity and global health security programs in low resourced settings.
The American Society of Health-System Pharmacists ASHP commits to education, practice standards, certification, and consultation related to antibiotic use for its over 45, members, including pharmacists, student pharmacists, and pharmacy technicians. In addition, ASHP will create an antibiotic stewardship certificate on developing and optimizing stewardship programs that will be released in ASHP also offers a consulting service to assist hospitals and health systems with the development or enhancement of stewardship programs. American Telemedicine Association Virginia, U.
American Telemedicine Association ATA , working to advance health through telecommunications technology called telehealth , commits to engaging its member United States network to conduct trend analysis of antibiotic use and identify best practices in antibiotic drug prescribing. Data collected will be used to facilitate member trainings, webinars, and other educational offerings to improve compliance with antibiotic stewardship. ATA is working to ensure that safe, affordable, and appropriate care is available when and where it is need for their patients.
American Urological Association Maryland, U. The American Urological Association AUA commits to partnering with CDC to generate and share data to inform antibiotic use strategies to reduce resistant infections following prostate biopsies. This partnership will allow for large dataset analyses that will provide evidence to potentially inform more granular recommendations on the best approaches to prevent such infections. The data may also provide evidence that can aid clinical management of other infections as well for example, urinary tract infections.
This effort is expected to take months. The American Veterinary Medical Association AVMA advocates for stronger veterinary oversight and responsible use of antibiotics to help protect the health of animals and people, animal welfare, and the food supply. AMRC offers research and development from pre-clinical leads to clinical proof of concept to bring new technologies to patients suffering from life-threatening drug-resistant infections.
- Main navigation.
- Thoracic Trauma and Critical Care.
- Antibiotic Policies: Fighting Resistance by Ian M. Gould (ebook).
- This is how India is fighting antimicrobial resistance.
- Antibiotic resistance: a rundown of a global crisis!
- Antimicrobial resistance.
AMRC is currently progressing three new antibiotic projects including a T3SS inhibitor pneumonia , metallo-beta-lactamase inhibitor gram-pathogens , and an antimicrobial peptide gram-pathogens , with another seven projects under review. Alliance companies are committed to contribute to and measure their efforts in fighting AMR across four key areas: research, appropriate use, access, and manufacturing and the environment. Earlier in , AMR Alliance generic and research-based pharmaceutical companies agreed on a framework that promotes responsible antibiotic manufacturing.
These companies took a further step by publishing the first list of discharge targets to guide environmental risk assessments for the manufacture of antibiotics. This publication is an important step in the journey as companies work toward achieving these target values. The Alliance companies will continue to take action and share their experiences to reduce environmental impact from the production of antibiotics. AMR Insights Netherlands AMR Insights commits to increasing the public professional awareness of the threat of antimicrobial resistance AMR by sharing knowledge and connecting experts through their network of up to 50, subscribers of their bimonthly newsletter.
Animal Health Institute Washington, D. Department of Agriculture USDA to improve the responsible use of antibiotics in food-producing and companion animals and to create science-based measurements that help veterinarians prescribe antibiotics responsibly. AHI will support work to develop innovative tools—including disease prevention and biosecurity practices, vaccines, new medical therapies, and alternatives to traditional antibiotics—to help veterinarians meet animal disease challenges.
AHI will serve as a resource to policy makers and stakeholders providing technical information on animal health products and champion efforts to support science and evidence-based solutions. Improving patient health by reducing inappropriate use of antibiotics is important to Anthem. By including antimicrobial resistance metrics in their value-based arrangements for both hospitals and physicians, Anthem commits to working with and financially rewarding providers for high and improved performance.
Antibiotic Policies: Fighting Resistance
This commitment includes working with care delivery transformation teams who interact directly with physicians to improve member education. ARAC is studying the impact of new California legislation, which limits the use of antibiotics in livestock, by testing purchased meat and human biological samples from the region for antibiotic-resistant germs that can cause infections.
ARAC is also launching an awareness campaign in 24 U. ASC-SC also commits to improving antimicrobial use in the community by collecting and tracking ambulatory antimicrobial use utilization in South Carolina. ASC-SC will also partner with healthcare providers and professional organizations in ambulatory settings to disseminate educational materials that encourage appropriate use of antimicrobials for community-acquired infections with a goal of 10 percent overall reduction in ambulatory antimicrobial use by Applied Silver, Inc.
California, U. Applied Silver, a health technology company, commits to sharing findings on the importance of hygiene in soft surfaces e. By spreading awareness of cleanliness in soft surfaces in hospitals, Applied Silver will reduce the spread of resistant pathogens. Applied Silver will advance efforts—including continuing education courses, webinars, workshops, and distribution of educational materials—to educate hospital staff, patients, regulatory agencies, and the community on the importance of incorporating soft surfaces interventions in standard infection control protocols in healthcare.
AquaTabs, Medentech, and Impact Water Ireland AquaTabs and Impact Water commit to expanding their reach to healthcare facilities and hospitals within the second half of Their solutions include water and environmental control, and safe drinking water. World Vision and Impact Water have selected a representative sample of healthcare facilities to implement its solutions from August to October with the objective to assess the most appropriate service and solution mix, and will report on its measures.
Argonne National Laboratory Illinois, U. Argonne National Laboratory commits to conducting research for improving detection of antimicrobial resistance mechanisms and prediction of antimicrobial susceptibility. First, by developing a panel that can detect hundreds of antimicrobial resistance genes at once September Second, using machine learning a subset of artificial intelligence to identify genetic markers for sequence-based prediction of antimicrobial susceptibility. This includes ongoing efforts to collect and integrate phenotypic susceptibility data for more than 38, publically available genomes by September As part of this, Argonne is collaborating with CDC on better predicting resistance in Clostridioides difficile.
Arkansas Department of Health Arkansas, U. The Arkansas Department of Health ADH will conduct more than 50 visits at Arkansas hospitals and nursing homes, evaluating practices and providing guidance to healthcare workers to bolster infection prevention and antibiotic stewardship programs during To prevent the spread of pathogens, ADH also commits to using results from a recent prevention effort to improve communication related to multidrug-resistant organisms and Clostridioides difficile when patients are transferred between healthcare facilities.
Lastly, ADH commits to supporting educational opportunities to improve awareness of antibiotic resistance, including co-hosting a statewide symposium on antibiotic resistance and stewardship in November Assist International New York, U. Assist International AI , a non-profit building humanitarian programs in more than 60 countries, commits to partnering to implement safe drinking water, sanitation, and hygiene WASH programs, including water filtration systems and technical services, at health facilities in low- and middle-income countries.
AI will also use lessons learned from the 52 sustainable Safe Water programs already implemented in partnership with GE Foundation and Emory University to better assess WASH in facilities and document implementation and evaluation methods. Asolva, Inc. Having served as IT professionals in healthcare for nearly 20 years, Asolva, Inc.
The Association for Professionals in Infection Control and Epidemiology APIC will work with its more than 15, members that save lives in hospitals and other healthcare settings to: increase clinician education and training through updated online and in-person educational programs, a joint position paper between APIC, SHEA, and SIDP, and a new chapter on antimicrobial stewardship in the APIC Text Online; conduct legislative and regulatory advocacy in support of funding for infection prevention and antimicrobial resistance programs; and develop consumer information and education on the proper use of antibiotics.
Over the next year, we will work with states, territories, and local health departments to identify areas for progress related to antimicrobial resistance across laboratory capacity, infection prevention and control, and antibiotic use. Knowing that resistance does not respect geopolitical borders, these state commitments will collectively lead to a healthier and safer U. Aster DM Healthcare India Aster DM Healthcare—an integrated healthcare service organization with 20 hospitals, clinics, and pharmacies across nine countries—commits to standardization of reporting of multi-drug resistant organisms MDRO across the chain of hospitals of Aster DM Group in India, and regular monitoring of MDRO rates across these hospitals with a data review every three months.
To contribute to solving the problem of inappropriate prescribing and drug resistant organism development, AtlantiCare commits to making hand washing a system wide goal, reminding all patients and employees to wash appropriately to minimize infection. AtlantiCare is also educating patients and staff about antibiotic resistance and appropriate prescribing of antibiotics, and undergoing a rigorous flu vaccination campaign for the community.
Atrium Health North Carolina, U. Atrium Health will work with its more than care locations and 44 hospitals to use Targeted Assessment for Prevention TAP strategies to reduce the Standardized Infection Ratio by a minimum of 10 percent by Atrium Health will also increase the number of its acute inpatient facilities that submit antibiotic use data to the National Healthcare Safety Network to 50 percent by Atrium Health will reduce inappropriate antibiotic prescribing by 10 percent by through the Atrium Health Outpatient Antimicrobial Stewardship program.
Globally, Atrium Health will continue partnerships with two hospitals in Guatemala by assisting them in developing recommendations, educational plans, and facility specific policies to reduce antibiotic resistance. Banka BioLoo Limited India Banka BioLoo Limited, an organization in India that promotes and develops environmentally-friendly products and services for human waste management, commits to implementing safe drinking water, sanitation, and hygiene WASH in 50 healthcare facilities in India where WASH facilities are not currently available, beginning in In partnership with other organizations, Banka BioLoo Limited will also conduct WASH awareness programs in healthcare facilities selected by partner organizations.
Progress will be measured through an annual review of healthcare facilities provided with WASH facilities. Better Life for All Foundation Nigeria The Better Life for All Foundation BLAF , a non-governmental organization in Nigeria, commits to sustaining grassroots education and enlightenment on the use and misuse of antibiotics while promoting awareness on the global public health threats of antibiotic resistance. Having successfully led several grassroots awareness on the dangers of antibiotics misuse and antimicrobial resistance AMR , BLAF will continue to reach out to adolescents, youths and nursing mothers with sensitization programs to promote infection prevention and control and antibiotics stewardship.
Through community outreach in the coming year, BLAF will advocate for social and behavioral changes that promote antibiotic stewardship and infection prevention and control. BD California, U. BD Becton, Dickinson and Company commits to helping slow the spread of antibiotic resistance by improving awareness, surveillance, infection prevention, and stewardship.
BD is mobilizing the Antimicrobial Resistance Fighter Coalition campaign to improve awareness; will support surveillance and research by collating, in specific projects, MedMinedTM data with the CDC to help better understand resistance in the U. Together with our partners, we will continue to support research and development of vaccines and novel biologics to prevent drug-resistant diseases and protect lives, especially in low- and middle-income countries.
We are also committed to investing in research to understand the burden of antimicrobial resistance on vulnerable populations in order to better quantify the impact of vaccines on drug-resistant infections and inform innovative approaches to preventing resistant infections. The platform will connect small and medium enterprises in Europe that are driven by research and development and focused on AMR with pharmaceutical companies, academia, investors and governmental institutions across the globe.
This will allow small and medium enterprises to discuss their specific challenges in bringing new antimicrobial treatments and diagnostics to the market. This will include global networking with a focus on AMR innovation, financing, and investments between AMR innovators and investors as well as between human and animal health stakeholders. The BIOMIN Research Center undertakes considerable scientific research and development to further enhance the sustainability of the livestock and aquaculture industries and to limit or decrease rates of antibiotic resistance on farms.
BIOMIN will continue to support this initiative through knowledge sharing of scientific findings and industry best practices along with technical consulting for commercial partners. Bio-Rad Laboratories California, U. Bio-Rad Laboratories commits to positively impacting appropriate and targeted use of antibiotic prescriptions by advancing diagnostic technologies that enable rapid identification of bacteria resistant to antibiotics from the current standard of 24 to 48 hours to less than an hour.
Biotia, an artificial intelligence, health tech firm, commits to advancing available technology such as sequencing-based laboratory workflow, software, and databases to help quickly and accurately identify and track antimicrobial resistance in healthcare settings. Biotia will conduct at least three pilots in hospitals to test viability and implementation of AMR products, as well as collect substantial amounts of DNA sequence data of pathogens and resistant germs.
These data will build a database to inform work in clinical settings and prevent infections. Biotia will also share the results of this work through at least one peer-reviewed manuscript, the press, scientific meetings, and with Biotia hospital customers. BioVersys AG focuses on research and development of small molecules acting on novel resistant bacterial targets and targeted microbiome therapies. Broad-spectrum antibiotics are often used as an alternative to penicillin, driving antibiotic resistance.
This assessment will improve antibiotic use in BJC facilities by allowing for the safest and most effective antibiotics to be prescribed. Boehringer Ingelheim Germany Boehringer Ingelheim, a company focused on advanced disease prevention for animal health, commits to reducing the use of and need for antibiotics in animals through an integrated health management approach using technologies that enable effective monitoring, early detection, and accurate diagnosis of resistant infections in animals.
Bolb Incorporated California, U. Bolb Incorporated is a manufacturer of germicidal Ultraviolet C Light Emitting Diode UVC LED platforms for chemical-free and touch-free disinfection of hospital environments to prevent exposure to infectious pathogens. Bolb commits to performing three hospital user studies during to measure the impact of its novel solutions and report results in infection prevention journals. The use of UVC in healthcare facilities is regulated by the Environmental Protection Agency and is currently deployed in more than hospitals globally.
The wider deployment of new LED capabilities has the potential to protect patients, nurses and workers, improving outcomes, and, as a result, lowering reliance on the use of antibiotics. Boston Scientific Massachusetts, U. Boston Scientific also commits to providing and expanding their single-use products designed to minimize the risk of infection transmission and improve efficiencies by eliminating the need for reprocessing and tracking.
Bugworks Research, Inc. We will continue to endeavor to beat superbugs via innovation, while making these products accessible and available to humanity. Bugworks will work closely with the government of India and other countries to promote stewardship of these novel antibiotics, so that these drugs stay effective for many years. C Diff Foundation Florida, U. C Diff Foundation commits to continuing to recognize the serious disease burden and significant economic impact that antimicrobial resistance AMR and healthcare-associated infections place on patients, their families, in communities, and the health care systems throughout the world.
As a part of the AMR Challenge, the C Diff Foundation will continue to acknowledge and share the importance of AMR stewardship programs; develop or expand ongoing campaigns at national or sub-national levels to promote and improve hand hygiene methods and compliance among health care providers; and make reliable and validated information available on antibiotic use and AMR stewardship programs, infection prevention, environment safety, and vaccines, therapeutics and diagnostics at the community and district levels to encourage best-practices.
Capital Health New Jersey, U.
HOA - Main Navigation - Desktop
Capital Health, a two-hospital health system serving 83, covered lives in New Jersey, commits to a collaborative approach to meet challenges posed by antibiotic resistance. Given the importance of supporting the proper use of these lifesaving drugs when they are needed most, each award agreement will include commitments to access and stewardship of these new antibiotics, vaccines, and diagnostics. CarePortMD, a platform that connects patients with clinicians in Delaware and Pennsylvania, commits to evidence-based prescribing of antibiotics. CarePortMD will implement a process for educating patients at the time of withholding antibiotics coupled with a protocol for scheduling a brief telemedical follow up assessment within hours.
This prescribing process provides patients and prescribers with either reassurance regarding the treatment plan, or an opportunity to modify use if a primary bacterial or emerging superinfection is identified. Catholic Relief Services Maryland, U. From , CRS will direct interventions at more than healthcare facilities. CRS commits to influence national health and water policies and budgets in each country to replicate the Clean Clinic Model across territories, effectively improving WASH in healthcare facilities across every facility. We believe that together our impact is greater. CDC is committed to providing the evidence base to identify the most effective safe drinking water, sanitation, and hygiene WASH and infection prevention and control IPC interventions in healthcare facilities.
CDC is also committed to providing technical assistance to partners to implement those interventions. CDC strengthens capacity through training and developing global guidance documents used worldwide. CDC will continue these activities to support partners, help ensure sustainability, and integrate WASH in healthcare facilities into larger health initiatives as resources permit. The Center for Global Safe Drinking Water, Sanitation, and Hygiene WASH at Emory University commits to the application of rigorous scientific methods to address the most pressing WASH research questions in healthcare facilities, such as determining the health outcomes of mothers and neonates who receive care from healthcare facilities that have safe or unsafe WASH conditions.
Emory commits to the continued dissemination of information and maintaining a web-based platform that facilitates connection, the sharing of best practices, and promotion of sustainable interventions among a community of practice of more than individuals from non-governmental organizations, government, engineering, and private corporations. The Center for Integrated Management of Antimicrobial Resistance CIMAR , a collaboration between Tufts University and Tufts Medical Center, commits to develop combination drug therapies for human and animal medicine that treat infections and slow antimicrobial resistance.
CIMAR engages in environmental surveillance in healthcare, soil, and water to control the spread of antimicrobial resistance, using tools from epidemiology, engineering, and the social sciences. Scientists find levels of resistance all over the country and map them to determine where the sources are located. CIMAR also commits to promoting the responsible use of antibiotics to improve patient treatment outcomes and is developing high school and undergraduate-level educational programs about antibiotic resistance.
Rapid and accurate diagnostic tests can help healthcare providers improve antibiotic prescribing decisions. Cepheid commits to develop and market molecular diagnostic products to optimize antimicrobial use in patients; provide diagnostic tests and disease tracking software that facilitates public health surveillance of infectious organisms, allowing for real-time detection of the organisms and drug resistance; collaborate directly with pharmaceutical companies to develop tests that support clinical trials of new antibiotics; and work with academic, industry, and government partners to develop sound public policy regarding the promotion of antimicrobial infection control and antibiotic stewardship programs.
CAPriCORN institutions will improve the tracking of inpatient antibiotic use and resistance by generating measures using a common data model from PCORnet, a national research data network.
These measures will be made available to local antibiotic stewardship and infection control programs, and shared across CAPriCORN sites to improve antibiotic use and slow spread of resistant infections. As a local health department responsible for direct healthcare facility engagement, the Chicago Department of Public Health CDPH commits to continued surveillance and response to antibiotic-resistant infections in healthcare settings. CDPH conducts onsite investigations and advises providers on infection control gap mitigation.
Issues with drug quality need to be tackled through comprehensive drug regulations. A national drug regulatory authority that is responsible and accountable for all aspects of drug regulation should be structured as an independent coordinating body in the ministry of health, separate from drug supply and management. Regulatory tools should be developed and personnel appropriately trained to ensure consistency and transparency in regulatory functions.
Fourth, the rational use of antimicrobials is essential for containing antimicrobial resistance. The promotion of national standard treatment guidelines calls for proper training and supervision of health personnel and for mechanisms to make diagnostic support available. Local incentive structures must be examined to identify factors influencing prescription practices. Methods of payment and reimbursement should be in line with standard treatment guidelines to discourage irrational use. Independent and unbiased information on antimicrobial use should be provided to health personnel and consumers.
Promotional activities by pharmaceutical companies should be regulated and monitored to prevent industry from misinforming patients and from offering financial incentives to providers. The overuse and misuse of antimicrobials in animals for human consumption must be addressed through surveillance of antimicrobial use in animals destined for food, training of veterinarians and farmers and, most critically, through legislative and regulatory measures. Fifth, policies and practices for the prevention and control of infections are indispensable in fighting antimicrobial resistance.
A proper organizational structure for developing and managing such policies and practices, combined with environmental designs for their application, need to be adopted in health facilities. These practices are also necessary in congregate settings and communities. Finally, operational research and research and development to make new tools available are crucial in combating antimicrobial resistance.
This includes improving current diagnostic tests and antimicrobials and designing incentives to engage industry in the development of new tools. Regulatory bottle-necks need to be eliminated and resources must be mobilized for rapid access to new tools. The drivers of antimicrobial resistance are interlinked, and so are the solutions. Single, isolated interventions have little impact. Strong leadership and political will are required to bring about bold changes in policies, organize health systems and legislative structures as required, and translate knowledge and recommendations into practice.
With new multidrug-resistant microorganisms being disseminated in tandem with well known older pathogens, the window of opportunity is rapidly closing: no action today, no cure tomorrow. Health Topics. World Health Statistics. That is what the health-care community in India is doing. Last year, Prime Minister Narendra Modi used his monthly radio address to urge doctors to join the effort. Still, the AMR threat remains real; containing it will require concerted effort.
In India, for example, we must implement the regulation, formulated by the Indian Health Ministry, controlling over-the-counter sales of antibiotics. Meanwhile, health-care communities in advanced economies must find the political will to reduce unnecessary antibiotic use by people, and in agriculture. Superbugs should strike fear in doctors and patients everywhere, but fear cannot lead to paralysis. The next time a patient arrives in my ward with a treatable infection, I need to be certain that the medicine I prescribe will be effective.
Abdul Ghafur , Disease Consultant. This article is published in collaboration with Project Syndicate. The views expressed in this article are those of the author alone and not the World Economic Forum. I accept. Regional Agenda Global Health India Future of Health and Healthcare This is how India is fighting antimicrobial resistance India is struggling with the rate that antibiotic resistance is growing in the developing country. Abdul Ghafur Disease Consultant. How do we build a sustainableworld?
Submit a video. Most Popular. Greta: the voice of climate activism who says 'don't listen to me' Sean Fleming 23 Sep More on the agenda.